ETF Holdings Breakdown of NEO

Stock Name	Neo Energy Metals Plc
Ticker	NEO(GBP) LSE
TYPE	Common Stock
Country	UK
ISIN	GB00BYWLRL80
LEI	213800WE14587VRQ5Y10

News associated with NEO

Neo Performance Materials (TSE:NEO) Hits New 1-Year High After Dividend Announcement: Neo Performance Materials Inc. (TSE:NEO – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after the company announced a dividend. The company traded as high as C$12.81 and last traded at C$12.54, with a volume of 171331 shares trading hands. The stock had previously closed at C$12.27. The newly announced […] - 2025-06-20 05:10:48
ProShare Advisors LLC Increases Position in NeoGenomics, Inc. (NASDAQ:NEO): ProShare Advisors LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,445 shares of the medical research company’s stock after purchasing an additional 11,831 shares during the quarter. […] - 2025-05-26 08:49:09
Tower Research Capital LLC TRC Cuts Stake in NeoGenomics, Inc. (NASDAQ:NEO): Tower Research Capital LLC TRC cut its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 80.8% during the 4th quarter, HoldingsChannel reports. The firm owned 2,449 shares of the medical research company’s stock after selling 10,292 shares during the quarter. Tower Research Capital LLC TRC’s holdings in NeoGenomics were worth $40,000 as of its […] - 2025-05-14 07:24:47
Neo Performance Materials (TSE:NEO) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says: Neo Performance Materials (TSE:NEO – Get Free Report) had its target price boosted by equities research analysts at Stifel Nicolaus from C$16.50 to C$17.50 in a research report issued to clients and investors on Monday,BayStreet.CA reports. Stifel Nicolaus’ price target would suggest a potential upside of 58.80% from the stock’s current price. Neo Performance Materials […] - 2025-05-14 05:24:49
Schonfeld Strategic Advisors LLC Sells 54,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO): Schonfeld Strategic Advisors LLC cut its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 76.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 16,280 shares of the medical research company’s stock after selling 54,330 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in NeoGenomics were worth $268,000 as of its […] - 2025-05-13 08:42:51
NeoGenomics (NASDAQ:NEO) Upgraded to Hold at StockNews.com: NeoGenomics (NASDAQ:NEO – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Tuesday. Other equities research analysts also recently issued reports about the company. The Goldman Sachs Group cut their price target on NeoGenomics from $15.00 to $10.00 and set a […] - 2025-05-13 07:28:54
Voya Investment Management LLC Sells 5,003,158 Shares of NeoGenomics, Inc. (NASDAQ:NEO): Voya Investment Management LLC trimmed its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 98.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,688 shares of the medical research company’s stock after selling 5,003,158 shares during the quarter. Voya […] - 2025-05-07 08:57:02
Hsbc Holdings PLC Trims Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Hsbc Holdings PLC reduced its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,569 shares of the medical research company’s stock after selling 2,430 shares during the quarter. Hsbc Holdings PLC’s holdings […] - 2025-05-07 07:56:56
Needham & Company LLC Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price: NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by research analysts at Needham & Company LLC from $18.00 to $8.50 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s target price would indicate a potential upside […] - 2025-05-01 05:52:52
NeoGenomics (NASDAQ:NEO) Shares Gap Down Following Weak Earnings: NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $9.97, but opened at $9.64. NeoGenomics shares last traded at $7.59, with a volume of 85,531 shares changing hands. The medical research company reported ($0.08) earnings per […] - 2025-04-30 06:12:52
Barclays PLC Has $3.95 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Barclays PLC increased its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 239,438 shares of the medical research company’s stock after buying an additional 8,537 shares during the quarter. Barclays PLC […] - 2025-04-28 08:34:55
Invesco Ltd. Decreases Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Invesco Ltd. reduced its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 6.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 410,967 shares of the medical research company’s stock after selling 27,789 shares during the quarter. Invesco Ltd. owned approximately 0.32% […] - 2025-04-25 08:08:53
Sterling Capital Management LLC Grows Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Sterling Capital Management LLC lifted its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 788.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,706 shares of the medical research company’s stock after buying an additional 3,289 shares during the period. […] - 2025-04-24 08:46:54
Rockefeller Capital Management L.P. Acquires 16,831 Shares of NeoGenomics, Inc. (NASDAQ:NEO): Rockefeller Capital Management L.P. grew its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 49.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,082 shares of the medical research company’s stock after acquiring an additional 16,831 shares during the period. Rockefeller Capital […] - 2025-04-23 08:41:01
Federated Hermes Inc. Raises Stock Position in NeoGenomics, Inc. (NASDAQ:NEO): Federated Hermes Inc. increased its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 4.4% in the fourth quarter, Holdings Channel reports. The firm owned 145,541 shares of the medical research company’s stock after acquiring an additional 6,086 shares during the period. Federated Hermes Inc.’s holdings in NeoGenomics were worth $2,399,000 as of […] - 2025-04-14 08:48:59
Geode Capital Management LLC Has $49.99 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO): Geode Capital Management LLC reduced its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 0.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,032,676 shares of the medical research company’s stock after selling 19,130 shares during the quarter. Geode Capital Management LLC’s holdings in NeoGenomics were worth $49,990,000 at […] - 2025-04-14 08:00:54
NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Franklin Resources Inc.: Franklin Resources Inc. lowered its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 28.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,461,406 shares of the medical research company’s stock after selling 582,434 shares during the quarter. Franklin Resources Inc. […] - 2025-04-07 08:40:53
Natixis Advisors LLC Grows Position in NeoGenomics, Inc. (NASDAQ:NEO): Natixis Advisors LLC increased its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,976 shares of the medical research company’s stock after purchasing an additional 2,994 shares during the period. Natixis […] - 2025-03-27 08:42:57
Cibc World Markets Corp Acquires New Position in NeoGenomics, Inc. (NASDAQ:NEO): Cibc World Markets Corp bought a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,932 shares of the medical research company’s stock, valued at approximately $197,000. Several other hedge funds and other institutional investors have […] - 2025-03-27 07:54:51
Swiss National Bank Raises Stake in NeoGenomics, Inc. (NASDAQ:NEO): Swiss National Bank boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 252,100 shares of the medical research company’s stock after purchasing an additional 2,600 shares during the quarter. Swiss National Bank’s holdings in NeoGenomics were worth $4,155,000 at the end of […] - 2025-03-26 08:50:59
Proficio Capital Partners LLC Makes New $372,000 Investment in NeoGenomics, Inc. (NASDAQ:NEO): Proficio Capital Partners LLC acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 22,561 shares of the medical research company’s stock, valued at approximately $372,000. Other hedge funds have also modified their […] - 2025-03-26 08:16:49
Neo Performance Materials (TSE:NEO) Price Target Raised to C$16.50 at Stifel Nicolaus: Neo Performance Materials (TSE:NEO – Get Free Report) had its price target hoisted by investment analysts at Stifel Nicolaus from C$15.00 to C$16.50 in a research note issued on Wednesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 71.88% from the company’s […] - 2025-03-21 05:26:43
Bank of New York Mellon Corp Grows Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Bank of New York Mellon Corp lifted its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 849,752 shares of the medical research company’s stock after buying an additional 15,269 shares during the quarter. Bank of New York Mellon Corp’s holdings in NeoGenomics […] - 2025-03-13 07:11:02
Keybank National Association OH Boosts Holdings in NeoGenomics, Inc. (NASDAQ:NEO): Keybank National Association OH lifted its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 22.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,092 shares of the medical research company’s stock after purchasing an additional 4,197 shares during the […] - 2025-03-11 08:10:59
Bank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price: NeoGenomics (NASDAQ:NEO – Get Free Report) had its target price reduced by Bank of America from $19.00 to $16.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the medical research company’s stock. Bank of America‘s price objective indicates a potential upside of 34.91% from the stock’s current […] - 2025-02-21 08:37:10
Needham & Company LLC Lowers NeoGenomics (NASDAQ:NEO) Price Target to $18.00: NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by analysts at Needham & Company LLC from $19.00 to $18.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 51.77% […] - 2025-02-21 08:37:09
NeoGenomics (NASDAQ:NEO) Sets New 12-Month Low After Earnings Miss: NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $12.01 and last traded at $11.91, with a volume of 366002 shares changing hands. The stock had previously closed at $14.42. The medical […] - 2025-02-19 06:07:03

NEO institutional holdings

The following institutional investment holdings of NEO have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 97,601 USD 698,823

2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 73,577 USD 526,811

2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 3,663 USD 26,227

Total = 174,841 USD 1,251,861
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	97,601	USD 698,823
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	73,577	USD 526,811
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	3,663	USD 26,227
Total =	174,841	USD 1,251,861

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.